论文部分内容阅读
75岁以上老年人一但罹患急性心肌梗死(MI),由于老龄化相关接受治疗的禁忌证相对较多,且药物严重毒副反应亦多,加之老龄化本身即为其独立危险因素之一,故往往较少接受有效干预治疗,但近年来这种状况有所改观。本文特就老年MI患者接受治疗决策的历史演变情况进行了汇总分析。对象与方法作者检索了相关数据库资料,共纳入了罹患MI的老年患者1期(2000年10月~2001年3月)半年内共280例,和2期(2005年10月~2006年10月)1年内的588例,所有对象总计868例,年龄均≥175岁,且相关试验均为随机双盲对照研究,其MI包括ST段抬高型
Aged over 75 years of age but with acute myocardial infarction (MI), due to aging related to the treatment of contraindications are relatively large, and the drug is also more serious side effects, combined with aging itself is one of its independent risk factors, It is often less effective treatment intervention, but in recent years this situation has changed. This article is a meta-analysis of the historical evolution of treatment decision-making in elderly patients with MI. Subjects and Methods The authors retrieved relevant database data and enrolled a total of 280 elderly patients aged from 1 (October 2000 to March 2001) with MI, and 2 patients (October 2005-October 2006) ) 588 cases within 1 year, all subjects a total of 868 cases, all ages ≥ 175 years old, and the relevant trials are randomized double-blind controlled study, MI including ST-segment elevation